Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/53811| Title: | EMERALD: A NovEl Machine LEaRning Assessment of Coronary Microvascular Function using CTCA and Angiography, and Evaluating the Effects of EmpagLiflozin on Coronary Microvascular Dysfunction in Adults with Angina | Monash Health Investigator(s): | Wong D. | Monash Health Department(s): | Cardiology (MonashHeart) | Registration Date: | 11-Apr-2025 | Monash Health Site(s): | Victorian Heart Hospital | Trial Phase: | Phase IV | Summary: | This study aims to see if using a commonly employed drug, first discovered for the treatment of diabetes, has a positive effect on improving a condition where the microscopic blood vessels of the heart are diseased or otherwise do not function normally. | Type: | Clinical trial | Registry ID: | ACTRN12625000282482 | URL: | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=387858& |
| Appears in Collections: | Clinical Trials |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.